Окончание статьи (ссылки на литер. источники)
ACKNOWLEDGEMENTS
This study was partially supported by the National Research Fund (KBN) via grant of Gdansk Medical University (ST-4).
REFERENCES
1. Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci 1999; 56: 270-9.
2. Jungers P, Khoa TN, Massy ZA, et al. Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: A multicentric study in the Ile de France district. Nephrol Dial Transplant 1999; 14: 898-902.
3. Sroczynski J, Antoszewski Z, Matyszczyk B, et al. Clinical assessment of treatment results for atherosclerotic ischemia of the lower extremities with intraarterial ozone injections. Pol Tyg Lek 1992; 47: 964-6.
4. Tylicki L, Nieweglowski T, Biedunkiewicz B, Burakowski S, Rutkowski B. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs – pilot study. Int J Artif Organs 2001; 24: 79-82.
5. Koren H, Devlin R, Graham D, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989; 139: 407-15.
6. Haugen E, Nath KA. The involvement of oxidative stress in the progression of renal injury. Blood Purif 1999; 17: 58-65.
7. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids 2001; 36 (suppl): S41-4.
8. Ueno I, Hoshino M, Miura T, Shinriki N. Ozone exposure generates free radicals in the blood samples in vitro. Detection by the ESR spin-trapping technique. Free Radic Res 1998; 29: 127-35.
9. Morena M, Cristol JP, Canaud B. Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif 2000; 18: 191-9.
10. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4- hydroxynonenal. Methods Enzymol 1990; 186: 407-21.
11. Anderson M. Enzymatic and chemical methods for the determination of glutathione. In: Dolphin D, Poulson R, Avramovic O, eds. Glutathione: Chemical, biochemical and medical aspects. John Wiley and Sons; 1989: pp. 339-65.
12. Garibaldi S, Aragno I, Odetti P, Marinari UM. Relationships between protein carbonyls, retinol and tocopherols level in human plasma. Biochem Mol Biol Int 1994; 34: 729-36.
13. Watkins B, Bermes E. Measurements of plasma hemoglobin. In: Sunderman F, ed. Seminar on biochemical hematology. Philadelphia: Institute for Clinical Science Inc 1979: pp. 57- 62.
14. Halliwell B, Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 1994; 102: 5-12.
15. Hasselwander O, Young IS. Oxidative stress in chronic renal failure. Free Radic Res 1998; 29: 1-11.
16. Girelli D, Olivieri O, Stanzial AM, et al. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: Relations to dialysis treatments, diet and cardiovascular complications. Clin Sci 1993; 84: 611-7.
17. Ward RA, McLeish KR. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs 1995; 19: 801-7.
18. Lonnemann G. The role of contaminated dialysate in hemodialysis-associated cytokine production. Contrib Nephrol 1990; 86: 121-7.
19. Morena M, Cristol JP, Bosc JY, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: A contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 422-7.
20. Koenig JS, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W. Antioxidant status in patients on chronic hemodialysis therapy: Impact of parenteral selenium supplementation. Wien Klin Wochenschr 1997; 109: 13-9.
21. United States Renal Data System: 1999 Annual Data Report. Am J Kidney Dis 1999; 34 (suppl 1): S1-176.
22. Eckardt KU. Pathophysiology of renal anemia. Clin Nephrol 2000; 53 (suppl): S2-8.
23. Miyata T, Notoya K, Yoshida K, et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 1997; 8: 260-70.
24. Boaz M, Green M, Fainauru M, Smetana S. Oxidative stress and cardiovascular disease in hemodialysis. Clin Nephrol 2001; 55: 93-100.
25. Biedunkiewicz B, Tylicki L, Nieweglowski T, et al. Beneficial effects of ozonated autohemotherapy in hemodialyzed patients with atherosclerotic ischemia lower limbs (abstract). Nephrol Dial Transplant 2002; 17 (suppl 7): S260.
26. Rice-Evans C, Miller N. Total antioxidant status in plasma and body fluids. New York: Academic Press Inc; 1994: pp. 279-93.
27. Pryor WA. Mechanisms of radical formation from reactions of
ozone with target molecules in the lung. Free Radic Biol Med 1994; 17: 451-65.
28. Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med 1995; 19: 115-9.
29. Freeman BA, Mudd JB. Reaction of ozone with sulfhydryls of human erythrocytes. Arch Biochem Biophys 1981; 208: 212-20.
30. Shinriki N, Suzuki T, Takama K, et al. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Haematologia 1998; 29: 229-39.
31. Bocci V, Luzzi E, Corradeschi F, et al. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes. J Biol Regul Homeost Agents 1993; 7: 133-8.
32. Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators Inflamm 1998; 7: 313-7.
33. Kubasova T, Horvath M, Kocsis K, Fenyo M. Effect of visible light on some cellular and immune parameters. Immunol Cell Biol 1995; 73: 239-44.
34. Hashimoto H, Mio T, Sumino K. Lipid abnormalities of erythrocyte membranes in hemodialysis patients with chronic renal failure. Clin Chim Acta 1996; 262: 137-45.
35. Cochrane CG. Mechanisms of oxidant injury of cells. Mol Aspects Med 1991; 12: 137-47.
36. Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J Biol Regul Homeost Agents 1996; 10: 31-53.
37. Bocci V, Valacchi G, Corradeschi F, et al. Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents 1998; 12: 67-75.
38. Zimran A, Wasser G, Forman L, Gelbart T, Beutler E. Effect of ozone on red blood cell enzymes and intermediates. Acta Haematol 2000; 102: 148-51.
39. Giunta R, Coppola A, Luongo C, et al. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol 2001; 80: 745-8.
40. Goldstein BD, Balchum OJ, Demopoulos HB, Duke PS. Electron paramagnetic resonance spectroscopy. Free radical signals associated with ozonization of linoleic acid. Arch Environ Health 1968; 17: 46-9.